Skip to content
Oncology Research Hub

Denver, Colorado

Cancer clinical trials in Denver, CO

131 cancer studies are recruiting participants at sites in Denver as of November 16, 2026, according to ClinicalTrials.gov. Oncology Research Hub can help you understand your options and connect with a study team.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Denver at a glance

  • 131 studies are recruiting at a site in Denver.
  • By phase: Phase 1 (34), Phase 1/2 (30), Phase 2 (11), Phase 2/3 (4), Phase 3 (38), No phase (3), Observational (11). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (91), university, hospital or other (33), government (7).
  • By research area: Breast Cancer (41), Lymphoma (28), Lung Cancer (27), Prostate Cancer (16), Pancreatic Cancer (10), Melanoma (9).
  • Most recent update to one of these records: November 16, 2026.

Breast cancer studies recruiting in Denver

Basic details from each study's public record (the 30 most recently updated of 131). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UCHealth - Cherry Creek
    Registry record
    NCT06058377 · updated
  2. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study sites
    Intermountain Health Cancer Center Saint Joseph ( Site 0062) · Rocky Mountain Cancer Centers (RMCC) ( Site 8006)
    Registry record
    NCT06966700 · updated
  3. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    Sarah Cannon Research Institute at HealthONE
    Registry record
    NCT07503808 · updated
  4. S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Study sites
    Colorado Blood Cancer Institute · National Jewish Health-Main Campus · Porter Adventist Hospital
    Registry record
    NCT03723928 · updated
  5. The Vanguard Study: Testing a New Way to Screen for Cancer

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Kaiser Permanente-Franklin
    Registry record
    NCT06995898 · updated
  6. A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 19 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    SCRI at HealthOne
    Registry record
    NCT06586957 · updated
  7. A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    Sarah Cannon Research Institute at HealthONE
    Registry record
    NCT07029399 · updated
  8. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    AdventHealth Porter
    Registry record
    NCT05334069 · updated
  9. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

    • Phase 3
    • Ages 18 to 60
    • Female participants
    Sponsor
    NRG Oncology
    Study sites
    Saint Joseph Hospital - Cancer Centers of Colorado · UCHealth - Cherry Creek
    Registry record
    NCT05879926 · updated
  10. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Study sites
    Colorado Blood Cancer Institute · Kaiser Permanente-Franklin · Rocky Mountain Cancer Centers-Midtown
    Registry record
    NCT06418204 · updated
  11. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Sarah Cannon Research Institute at HealthOne
    Registry record
    NCT06465069 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Denver, CO on ClinicalTrials.gov.

Lung cancer studies recruiting in Denver

  1. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    Kaiser Permanente-Franklin · National Jewish Health-Main Campus
    Registry record
    NCT04267848 · updated
  2. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Kaiser Permanente-Franklin
    Registry record
    NCT06498635 · updated
  3. A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Bayer
    Study site
    Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's
    Registry record
    NCT06914128 · updated
  4. A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Rocky Mountain Cancer Centers LLP · Rocky Mountain Cancer Centers,LLP
    Registry record
    NCT07144280 · updated
  5. Phase 1 Study of PF-08046033 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Presbyterian/St Lukes Medical Center · Sarah Cannon Research Institute at HealthONE
    Registry record
    NCT07519655 · updated
  6. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Kaiser Permanente-Franklin
    Registry record
    NCT04181060 · updated
  7. A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    Sarah Cannon Cancer Institute at HealthONE
    Registry record
    NCT06720987 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Denver, CO on ClinicalTrials.gov.

Prostate cancer studies recruiting in Denver

  1. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Amgen
    Study site
    Rocky Mountain Cancer Centers
    Registry record
    NCT04221542 · updated
  2. A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Regeneron Pharmaceuticals
    Study site
    Sarah Cannon Research Institute (SCRI)
    Registry record
    NCT03972657 · updated
  3. Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Sarah Cannon Research Institute 1
    Registry record
    NCT06800313 · updated
  4. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Kaiser Permanente-Franklin
    Registry record
    NCT06931340 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Denver, CO on ClinicalTrials.gov.

Lymphoma studies recruiting in Denver

  1. A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Study site
    Colorado Blood Institute
    Registry record
    NCT07221500 · updated
  2. A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Colorado Blood Cancer Institute ( Site 7000)
    Registry record
    NCT07519772 · updated
  3. A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

    • Phase 2
    • Ages 1 to 30
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
    Registry record
    NCT04546399 · updated
  4. A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

    • Phase 3
    • Ages 5 to 60
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
    Registry record
    NCT05675410 · updated
  5. A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Colorado Blood Cancer Institute
    Registry record
    NCT07101328 · updated
  6. A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Lyell Immunopharma, Inc.
    Study site
    Colorado Blood Cancer Institute
    Registry record
    NCT07188558 · updated
  7. A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Colorado Blood Cancer Institute
    Registry record
    NCT07226843 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Denver, CO on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Denver

  1. A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Incyte Corporation
    Study site
    Investigative Site US071
    Registry record
    NCT07522073 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Denver, CO on ClinicalTrials.gov.

Ask about studies near Denver

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Colorado

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call